about
Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology ModelsHCV Kinetic Models and Their Implications in Drug DevelopmentBridging Systems Medicine and Patient NeedsModeling and Simulation Approaches for Cardiovascular Function and Their Role in Safety AssessmentA Philosophical Framework for Integrating Systems Pharmacology Models Into PharmacometricsExposure-response modeling of clinical end points using latent variable indirect response modelsA mechanistic, model-based approach to safety assessment in clinical developmentApproaching Pharmacometrics as a Paleontologist Would: Recovering the Links Between Drugs and the Body Through ReconstructionAgent-Based Modeling in Systems PharmacologySystems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of TuberculosisPhIN: A Protein Pharmacology Interaction Network DatabaseBioModels: Content, Features, Functionality, and UseLewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice VersaVNP: Interactive Visual Network Pharmacology of Diseases, Targets, and DrugsCPT: Pharmacometrics and Systems PharmacologyModeling and simulation at the interface of nonclinical and early clinical drug developmentSystematic Quality Control Analysis of LINCS DataBasic Concepts in Population Modeling, Simulation, and Model-Based Drug DevelopmentVisualization and communication of pharmacometric models with berkeley madonnaFractal Geometry-Based Decrease in Trimethoprim-Sulfamethoxazole Concentrations in Overweight and Obese People.Identifying tinnitus-related genes based on a side-effect network analysis.Open access: a new model for publishing in the pharmacological sciencesDatabase of Optimized Proteomic Quantitative Methods for Human Drug Disposition-Related Proteins for Applications in Physiologically Based Pharmacokinetic Modeling.Comparisons of Analysis Methods for Proof-of-Concept Trials.White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulation.Clinical Trial Simulation to Inform Phase 2: Comparison of Concentrated vs. Distributed First-in-Patient Study Designs in Psoriasis.Modeling and simulation as a tool to bridge efficacy and safety data in special populations.Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome.Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic-pharmacodynamic data.Modeling and simulation of count data.Predicting QTc Prolongation in Man From Only In Vitro Data.Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.IDEA: Integrated Drug Expression Analysis-Integration of Gene Expression and Clinical Data for the Identification of Therapeutic Candidates.Relationships Between Pharmacovigilance, Molecular, Structural, and Pathway Data: Revealing Mechanisms for Immune-Mediated Drug-Induced Liver Injury.Relating Chemical Structure to Cellular Response: An Integrative Analysis of Gene Expression, Bioactivity, and Structural Data Across 11,000 Compounds.Pharmacokinetics of Anti-VEGF Agent Aflibercept in Cancer Predicted by Data-Driven, Molecular-Detailed Model.The Many Flavors of Model-Based Meta-Analysis: Part I-Introduction and Landmark Data.Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and TherapyCombined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests.Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.
P1433
Q26779458-CAD106BE-0AC3-4C6C-9B12-A6359500AE09Q26801602-5C10AA06-6B61-4C59-8C1B-E887BC97BE04Q26801606-A121A09C-C0C9-4F36-838A-22BFFBD27C91Q26801610-D93BA47C-06EA-4814-BB7E-C77F2776E000Q28070251-569D94A9-1283-4132-A394-C6992E2975F8Q28389062-A551224A-450D-4AD2-84E8-E1E0B5205F95Q28395802-D606FBFF-4317-4EAF-9DAB-C6228CB85919Q28601845-783CD159-7B96-47E0-B280-D337CCA58FDDQ28602444-CE49D341-6D42-4DD8-BCD3-63BBDA37A953Q28649769-B118928F-0959-4954-A7FD-6BC9413B99E7Q28649771-FDB2CF7D-370C-40F9-80B3-1EFD85C5E03EQ28652344-BE4AD3AB-00F7-4CF1-B89D-A00FD1147574Q28652486-DE744760-8ADA-4734-B1B7-2CADDE694442Q28659025-5B042007-0604-4588-9302-B1CB15F24AF6Q28709637-FE595F74-275B-4460-BC57-C158E9B74EB3Q28709672-F569E5A8-156D-4A5B-A125-01BADB2DF26FQ28818488-34C7FF5B-EF03-40C1-BE36-CC0629F673A3Q29013931-0CE6E038-4F35-41F2-A241-82B18E8327A9Q29584444-560B2DF9-43D1-4FDD-9F5D-A0460C3620B4Q30395441-AB00643F-5D8A-4FDA-B877-DEE9A8A10922Q30443419-2A0F51D0-81D6-4B9D-A5E9-41698E0CC3D3Q30486238-6656C748-4047-4D9C-8FD3-A3A1FBB3F26BQ30490654-2E400086-805E-44F3-AC0E-76E84C68EFA2Q30537763-84CAE990-6283-4272-8F2C-1D60C54BA451Q30540355-5B80D815-4C39-4BD2-BAB8-9F259F4388E9Q30542069-A269DF95-CF3C-440F-A865-C3D523243342Q30654043-B2728035-7506-4AE5-8444-AD4BE5C2C964Q30655795-50080F10-3ABD-4B32-BD7A-18EDF06F5051Q30728857-ADCF9DD1-13BB-4279-B8BE-34ABFCEB5B0AQ30842267-4DD90D1E-EC9B-4FC6-B72A-E68770E17152Q30843780-B4B89C02-2FD2-4F53-B3C7-2D568BC48869Q30867699-88D9DCC8-5D18-4990-895A-F647C3E85E48Q30990059-E84DAFF8-3F60-4E87-B058-2A0D7D64BE8FQ30990061-9BC01826-B18B-4659-9D2E-A89AD1EC5C5AQ31017429-58529A70-A760-4DF6-B8EC-68DB26A9C699Q31037873-1C0AB1E8-5088-4EB8-86ED-7BBC40AC55DCQ31051371-D1B87076-8872-4622-B978-E2170D56C4A3Q31074800-2CF835A9-E20B-4812-B6A9-CD079849474FQ31074808-73970F31-CBAF-4EA5-9A1B-23965855E579Q31117636-999A6E0E-968E-445C-918F-989813D048B4
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
name
CPT: pharmacometrics & systems pharmacology
@ast
CPT: pharmacometrics & systems pharmacology
@en
CPT: pharmacometrics & systems pharmacology
@es
CPT: pharmacometrics & systems pharmacology
@nl
type
label
CPT: pharmacometrics & systems pharmacology
@ast
CPT: pharmacometrics & systems pharmacology
@en
CPT: pharmacometrics & systems pharmacology
@es
CPT: pharmacometrics & systems pharmacology
@nl
altLabel
CPT Pharmacometrics Syst Pharmacol
@en
CPT: Pharmacometrics & Systems Pharmacology
@en
prefLabel
CPT: pharmacometrics & systems pharmacology
@ast
CPT: pharmacometrics & systems pharmacology
@en
CPT: pharmacometrics & systems pharmacology
@es
CPT: pharmacometrics & systems pharmacology
@nl
P123
P31
P3181
P1055
P1156
21100248023
P1277
P1476
CPT: pharmacometrics & systems pharmacology
@en